Rapid detection of Group B (GBS) from artificial urine samples based on IFAST and ATP bioluminescence assay: from development to practical challenges during protocol testing in Kenya

• Published in: Analyst (London) Vol. 144; no. 23; pp. 6889 - 6897
• Main Authors: Ngamsom, Bongkot, Wandera, Ernest Apondi, Iles, Alexander, Kimani, Racheal, Muregi, Francis, Gitaka, Jesse, Pamme, Nicole
• Format: Journal Article
• Published: 18.11.2019
• ISSN: 0003-2654; 1364-5528
• DOI: 10.1039/c9an01808e

We report the rapid detection (20 min) of Streptococcus agalactiae , Group B Streptococcus (GBS) employing on-chip magnetic isolation of GBS based on immiscible filtration assisted by surface tension (IFAST), followed by detection of the isolated GBS using an adenosine triphosphate (ATP) bioluminescence assay. Up to 80% GBS cells were isolated from spiked artificial urine samples with linear responses of bioluminescence signals from isolated cells at 2.3 × 10 2 -9.1 × 10 5 CFU mL −1 , demonstrating great promise for point-of-care detection of pathogenic bacteria in screening urine samples from pregnant women. Practical challenges during initial testing of the developed protocol with urine samples in Kenya are also described. Microfluidic IFAST/ATP bioluminescence assays were explored for potential point-of-care detection of Group B Streptococcus (GBS) in urine in low-resource settings.